New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...
AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...
Zacks.com on MSN1d
Gilead Science to Report Q3 Earnings: What's in the Cards?Biotech giant Gilead Sciences, Inc. GILD is scheduled to report third-quarter 2024 results on Nov. 6, after market close. The ...
In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Legend Biotech (LEGN – Research ...
Viking Therapeutics (VKTX) stock is reversing gains despite earlier announcing strong results for its experimental obesity pill ...
Newly created position to lead efforts focused on continued growth and salesSOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell ...
In the closing weeks of the election, Kamala Harris is constantly campaigning alongside musicians and celebrities in hopes of ...
Berkshire Hathaway (NYSE:BRK.B) (NYSE:BRK.A), the sprawling investment company built by investing legend Warren Buffett, ...
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
On Monday, Legend Biotech Corp (LEGN) stock saw a modest uptick, ending the day at $45.3 which represents a slight increase of $0.56 or 1.25% from the prior close of $44.74. The stock opened at $44.96 ...
In 1983, one ambitious sci-fi miniseries dared to take a high-stakes interstellar conflict and set all the action on Earth.
New results show Eli Lilly Ebglyss (lebrikizumab-lbkz) improved skin (including hand and face) and itch among patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback